Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular ...
Efficacy and Safety of Olezarsen in Managing Hypertriglyceridemia ...
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia ...
Olezarsen and Severe Triglycerides: A New Way to Reduce Pancreatitis Risk
ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD - YouTube
Olezarsen reduces triglyceride levels in adults with ...
Olezarsen para Hipertrigliceridemia em pacientes de alto risco ...
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia | New ...
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis ...
Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides ...
Olezarsen significantly reduces triglyceride levels by ~ 50% vs placebo ...
The impact of olezarsen on hypertriglyceridemia in high cardiovascular ...
Ionis’ Olezarsen Achieves Phase III Success in Severe Hypertriglyceridemia
Olezarsen benefits hypertriglyceridemia patients at high cardiovascular ...
Olezarsen Shows Promising Results in Reducing Triglycerides and ...
ACC 2024: Safety and Efficacy of Olezarsen in Patients With ...
Estudio sobre el uso de Olezarsen (ISIS 678354) en pacientes con ...
Olezarsen Significantly Reduces Triglycerides and Pancreatitis Risk in ...
Olezarsen for High Triglycerides Clinical Trial 2024 | Power
Olezarsen Proves Efficacy in Severe Hypertriglyceridemia, With Nicholas ...
Study: Olezarsen Effective Treatment for High Triglycerides | Mass ...
Olezarsen for treating severe hypertriglyceridaemia - NIHR Innovation ...
Olezarsen for hypertriglyceridemia in patients at high cardiovascular ...
Experimental drug Olezarsen may reduce hypertriglyceridemia in high ...
olezarsen (Ionis-APOCIII-LRx) / Ionis
Olezarsen « New Drug Approvals
Ionis reports data from study of olezarsen for hypertriglyceridemia
Olezarsen for Hypertriglyceridaemia in High-Risk Patients
Olezarsen Achieves Normal Triglyceride Levels in 80% of Patients
Positive Phase III results for Ionis’ olezarsen in severe ...
Ionis: Shares Soar on Positive Phase 3 Top-Line Results for Olezarsen ...
Olezarsen in Patients With Hypertriglyceridemia at High Cardiovascular ...
Impacto del Olezarsen en la Hipertrigliceridemia y Riesgo ...
CORE/CORE2: Olezarsen Achieves Primary Endpoint in Severe ...
Olezarsen Cuts Triglyceride Levels at 6 Months in Essence Study
Olezarsen en pacientes con hipertrigliceridemia severa - MedEcs
The ASO drug olezarsen targets familial chylomicronemia syndrome ...
Bridge-TIMI 73a: Olezarsen in patients with hypertriglyceridemia at ...
Olezarsen shows promise as new therapy to reduce triglyceride levels
Olezarsen Tryngolza,价格,效果,说明书-肿瘤药品网
Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe ...
FDA Approves Olezarsen (TRYNGOLZA) for Triglyceride Reduction in Adults ...
Ionis outlines >$2B peak sales target for olezarsen as new launches and ...
Ionis outlines 2026 revenue of $875M-$900M while lifting olezarsen peak ...
Olezarsen Shows Promise in Reducing Triglycerides: Insights from Phase ...
HMN 2025: How Olezarsen reduces levels of the blood fat, triglycerides ...
Focus – Olezarsen shows promise in hypertriglyceridemia | R3I
Olezarsen Shows Ability to Reduce Triglycerides for Patients with FCS ...
Olezarsen Effectively Lowers Triglycerides | www.PhysiciansWeekly.com
Olezarsen reduces triglycerides, pancreatitis events in familial ...
Ionis Reports Promising Phase III Results for Olezarsen in ...
Olezarsen lowers pancreatitis risk in severe hypertriglyceridemia
Olezarsen Cuts Triglyceride Levels in Half Among Patients With ...
Olezarsen Cuts Triglyceride Levels in Patients With Moderate ...
Ionis' Olezarsen Cuts Triglycerides 72%, Pancreatitis Events 85% | IONS ...
DailyMed - TRYNGOLZA- olezarsen sodium injection, solution
Olezarsen for Familial Chylomicronemia Syndrome | New England Journal ...
Efficacy and safety of Olezarsen in treating hypertriglyceridemia: a ...
FDA Approves Olezarsen as Adjunct to Diet for Familial Chylomicronemia ...
Olezarsen Fast Tracked for Familial Chylomicronemia Syndrome
Olezarsen riduce i trigliceridi nei pazienti ad alto rischio ...
Support for Every Step™ | TRYNGOLZA® (olezarsen) Injection
Tryngolza(olezarsen)说明书-价格-功效与作用-副作用-香港济民药业
3期临床试验结果积极！Olezarsen可降低中度高甘油三酯血症患者的甘油三酯水平-上市-医保-临床适应症-香港济民药业
TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for ...
FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults ...
Plozasiran vs Olezarsen: Two RNA Paths to ApoC-III Control
Olezarsen: Una Nueva Esperanza en el Tratamiento de la ...
Tryngolza (Olezarsen Injection, for Subcutaneous Use): Side Effects ...
Ionis Pharmaceuticals, Inc. (IONS) Discusses Detailed Phase III Results ...
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ...
Olezarsen: oligonucleótidos antisentido para regular los triglicéridos
Olezarsen's EMA approval: When is the new medicine for lowering ...
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome ...
ApoC3 反义寡核苷酸 Olezarsen（Tryngolza™），上市背后的科学决策 - 知乎
Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia ...
The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug ...
Ionis’ Tryngolza (Olezarsen) Receives the US FDA’s Approval to Treat ...
只需每月一针，FDA批准"first-in-class"长效降脂疗法|FDA_新浪新闻
Olezarsen: erste Therapie speziell bei FCS - ifap
Tryngolza(Olezarsen) Approved For FCS After Positive Phase 3
BREAKING NEWS: We’re thrilled to share we have received U.S. FDA ...
Optimizing cardiovascular health: a systematic review and meta-analysis ...
疾病指标降低100%！Ionis反义寡核苷酸疗法Olezarsen的III期临床成功_腾讯新闻
Clinical Trial Results | TRYNGOLZA™ (olezarsen) Injection
Arrowhead Pharmaceuticals: Important Catalysts And Some Challenges ...
How TRYNGOLZA® Works | TRYNGOLZA® (olezarsen) Injection
Safety and Efficacy of the Novel RNA Interference Therapies for ...
:%0A%0AOlezarsen%20for%20High%20Triglycerides.png?md=1)
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/ca9ef979-0207-4e37-b392-91618ebc1841.jpg)
